Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8750820 | Respiratory Investigation | 2017 | 9 Pages |
Abstract
No safety concerns for long-term T+O treatment were identified in Japanese patients with COPD. A numerical improvement in lung function was observed with T+O treatment compared to O monotherapy.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Masakazu MD, PhD, Motokazu MD, Ayako MS, Wataru MS, Lars MD, Kay MD, Yoshinosuke MD, PhD,